PD-L1 expression level, TMB, or effector T cell IFN-γ gene signatures may each correlate with certain characteristics of a tumor immune micro-environment (TIME) that will be optimal for PD-(L)1 immune checkpoint blockade (ICB). This evidence concerns the gene IFNG and neoplasm.